Briefings Archive

Period:

(Week in Review)
RESEARCH
  • Monoclonal antibody does not reduce SARS-COV-2 viral load in humans
  • Hospitalizations for non-covid-19 conditions in New York confirmed lower this Spring
  • Can aspirin improve inpatient mortality for patients with covid-19?

RESEARCH
  • Can aspirin improve inpatient mortality for patients with covid-19?
POLICY
  • Final vaccine rollout recommendations from National Academies of Science

RESEARCH
  • Monoclonal antibody does not reduce SARS-COV-2 viral load in humans
  • Update on Regeneron

RESEARCH
  • Lessons from Sweden: don’t combine covid-19 and crowded conditions
POLICY
  • Compounding crises abound

RESEARCH
  • Hospitalizations for non-covid-19 conditions in New York confirmed lower this Spring
  • A decrease in medical care during the pandemic. Why that may not mean what you think

POLICY
  • New analysis: 130,000-210,000 United States coronavirus deaths were avoidable
  • Is covid-19 beyond control? Beyond belief

(Week in Review)
POLICY
  • Universities and coronavirus testing. An update from the ivory towers
  • Lingering questions about a vaccine rollout
  • New CDC travel safety recommendations. Masks on before "wheels up!"

(Week in Review)
RESEARCH
  • Another hope dashed? Tocilizumab not as promising as hoped in a new trial
  • Who would and who would not get a covid-19 vaccine in the United States?
  • Repurposed antiviral drugs unable to lower covid-19 mortality, interim WHO study finds

RESEARCH
  • Suicides and the covid-19 pandemic. Good news from three countries
POLICY
  • Universities and coronavirus testing. An update from the ivory towers
  • Politics trumps protections in vaccine development

RESEARCH
  • Focus on monoclonal antibodies
  • Another hope dashed? Tocilizumab not as promising as hoped in a new trial
  • Four clinical studies on the monoclonal antibody Tocilizumab. What does it all mean?

RESEARCH
  • Who would and who would not get a covid-19 vaccine in the United States?
POLICY
  • New CDC travel safety recommendations. Masks on before "wheels up!"
  • Testing accountability and ability mismatch remain

RESEARCH
  • Will monoclonal antibodies quieting our own immune system help covid-19 patients?
POLICY
  • Lingering questions about a vaccine rollout

RESEARCH
  • Repurposed antiviral drugs unable to lower covid-19 mortality, interim WHO study finds
POLICY
  • Why is the Trump administration so "e-mask-ulated"?

(Week in Review)
POLICY
  • The CDC releases "interim considerations" for school-based coronavirus testing
  • FDA seeks to reclaim trust
  • What's in a name? All about Emergency Use Authorizations
  • FDA issues EUA for first multiplexed diagnostic test

(Week in Review)
RESEARCH
  • Excess Deaths in the United States among the worst when compared to similar nations
  • Monoclonal antibody trial halted for safety concern
  • Covid-19 thought to increase abnormal blood clots. What do the CT scans say?

RESEARCH
  • Covid-19 thought to increase abnormal blood clots. What do the CT scans say?
POLICY
  • The CDC releases "interim considerations" for school-based coronavirus testing

RESEARCH
  • Psychiatric disease and covid-19 risk
POLICY
  • FLOTUS makes a covid-19 statement, falsely implying vitamins have a role in treatment

RESEARCH
  • Covid-19 in primary care practices
POLICY
  • FDA seeks to reclaim trust

RESEARCH
  • First proven covid-19 reinfection described in detail. Is this likely to be common?
POLICY
  • What's in a name? All about Emergency Use Authorizations

RESEARCH
  • Excess Deaths in the United States among the worst when compared to similar nations
POLICY
  • FDA issues EUA for first multiplexed diagnostic test

(Week in Review)
POLICY
  • Here we go again. Are we seeing the feared Fall surge?
  • Turning the screws on hospitals not reporting data to HHS
  • Confirmation of new transmission vector; CDC says some airborne spread possible
  • Vaccine update: White House turns on its own Food and Drug Administration
  • "Warp Speed" may have blown past solutions

(Week in Review)
RESEARCH
  • Final remdesivir results published after 139 days of waiting
  • An early hopeful for an effective covid-19 therapy comes up short in a major trial
  • Facemasks have no effect on oxygen levels even in users with existing lung disease

RESEARCH
  • Final remdesivir results published after 139 days of waiting
POLICY
  • Here we go again. Are we seeing the feared Fall surge?
  • Turning the screws on hospitals not reporting data to HHS

RESEARCH
  • An early hopeful for an effective covid-19 therapy comes up short in a major trial
  • Long-term effects of SARS-CoV-2 Infection: Heart and Mind
  • Long-Haulers and Post-viral Syndromes
  • Brain Fog
  • Heart Dysfunction
POLICY
  • FDA prevails in vaccine requirements

RESEARCH
  • Facemasks have no effect on oxygen levels even in users with existing lung disease
POLICY
  • Confirmation of new transmission vector; CDC says some airborne spread possible
  • End of the road for long-haulers?

RESEARCH
  • The USS Roosevelt covid-19 outbreak
POLICY
  • Vaccine update: White House turns on its own Food and Drug Administration

RESEARCH
  • What is the prognosis for the President of the United States?
POLICY
  • “Warp Speed” may have blown past solutions

(Week in Review)
POLICY
  • Goodwill only goes so far. Reimbursement in the time of covid-19
  • Life science companies commit to the worldwide distribution of covid-19 diagnostics, therapeutics and vaccines
  • New authorization for point-of-care testing
  • CMS to follow through on threat that hospitals must report data to HHS, not CDC

(Week in Review)
RESEARCH
  • Comparing current vaccine candidates
  • The body's reaction to covid-19 may be, in parts, counterproductive
  • Covid-19 vaccine tested in older adults

RESEARCH
  • Covid-19 vaccine tested in older adults
POLICY
  • Goodwill only goes so far. Reimbursement in the time of covid-19

RESEARCH
  • The body's reaction to covid-19 may be, in parts, counterproductive
POLICY
  • Life science companies commit to the worldwide distribution of covid-19 diagnostics, therapeutics and vaccines